[go: up one dir, main page]

MX2017008423A - Formulaciones transdérmicas. - Google Patents

Formulaciones transdérmicas.

Info

Publication number
MX2017008423A
MX2017008423A MX2017008423A MX2017008423A MX2017008423A MX 2017008423 A MX2017008423 A MX 2017008423A MX 2017008423 A MX2017008423 A MX 2017008423A MX 2017008423 A MX2017008423 A MX 2017008423A MX 2017008423 A MX2017008423 A MX 2017008423A
Authority
MX
Mexico
Prior art keywords
transdermal formulations
transdermal
formulations
directed
present disclosure
Prior art date
Application number
MX2017008423A
Other languages
English (en)
Inventor
Hoffman Steven
Original Assignee
Hoffman Steven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffman Steven filed Critical Hoffman Steven
Publication of MX2017008423A publication Critical patent/MX2017008423A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente exposición se dirige a composiciones transdérmicas y humectantes.
MX2017008423A 2014-12-23 2015-12-23 Formulaciones transdérmicas. MX2017008423A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462096148P 2014-12-23 2014-12-23
PCT/US2015/000302 WO2016105530A1 (en) 2014-12-23 2015-12-23 Transdermal formulations

Publications (1)

Publication Number Publication Date
MX2017008423A true MX2017008423A (es) 2017-10-26

Family

ID=55221489

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008423A MX2017008423A (es) 2014-12-23 2015-12-23 Formulaciones transdérmicas.

Country Status (14)

Country Link
US (3) US20160193339A1 (es)
EP (1) EP3237013B1 (es)
JP (2) JP6836991B2 (es)
KR (1) KR20170117390A (es)
CN (1) CN107405298A (es)
AU (1) AU2015371253B2 (es)
BR (1) BR112017013329A2 (es)
CA (1) CA2968046A1 (es)
EA (1) EA035087B1 (es)
ES (1) ES2953955T3 (es)
IL (1) IL252062A0 (es)
MX (1) MX2017008423A (es)
PH (1) PH12017500836A1 (es)
WO (1) WO2016105530A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10272068B2 (en) 2012-01-17 2019-04-30 Tyme, Inc. Pharmaceutical compositions and methods
US20130183263A1 (en) 2012-01-17 2013-07-18 Steven Hoffman Pharmaceutical compositions and methods
US10646552B2 (en) 2012-01-17 2020-05-12 Tyme, Inc. Pharmaceutical compositions and methods
EP3247988A4 (en) 2015-01-23 2018-12-19 Vanderbilt University A robust interferometer and methods of using same
EP3612225A1 (en) * 2017-04-21 2020-02-26 Steven Hoffman Compositions and methods for treating retinopathy
KR20200052934A (ko) * 2017-09-15 2020-05-15 타임, 인크. 경피 제제
US20200163952A1 (en) * 2018-11-26 2020-05-28 Steven Hoffman Compositions and methods for treating nerve agent exposure
US20200282014A1 (en) * 2019-03-05 2020-09-10 Hoffman Technologies Llc Percutaneous anti-microbiota formulations
AU2020276605A1 (en) 2019-05-14 2022-01-20 Tyme, Inc. Compositions and methods for treating cancer
CA3179419A1 (en) * 2020-04-08 2021-10-14 Hoffman Technologies Llc Methods of treating conditions characterized by insulin deficiency in animals
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61210024A (ja) * 1985-03-14 1986-09-18 Yamanouchi Pharmaceut Co Ltd 外用塩酸ニカルジピン製剤
US4677131A (en) 1985-11-01 1987-06-30 Merck & Co., Inc. Cyclic ureas as dermal penetration enhancers
US5238933A (en) 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions
US5618850A (en) * 1995-03-09 1997-04-08 Focal, Inc. Hydroxy-acid cosmetics
US20040121023A1 (en) 1998-11-02 2004-06-24 Victor Stevens Composition to alleviate pain and topical method of applying same
CA2360300C (en) 1999-02-09 2008-08-26 Samyang Corporation A transdermal composition of an antivomiting agent and a preparation containing the same
CN1167412C (zh) * 2000-08-03 2004-09-22 浙江大学 一种经皮理疗用药物凝胶
DE10158199A1 (de) 2001-11-27 2003-06-18 Beiersdorf Ag Juckreizstillende kosmetische und dermatologische Zubereitungen
AU2012216593B2 (en) 2002-11-01 2014-09-25 Allergan Sales, Llc Compositions and methods for transdermal oxybutynin therapy
EP1670433B1 (en) 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
US20060140988A1 (en) 2004-12-23 2006-06-29 Guohua Chen Visco-supplement composition and methods
KR20080000647A (ko) 2005-04-28 2008-01-02 오노 야꾸힝 고교 가부시키가이샤 경피 흡수 제제
KR100658436B1 (ko) * 2005-12-09 2006-12-27 한국화학연구원 아데노실코발라민 함유 피부질환 치료용 외용제 조성물
EP1800671A1 (de) * 2005-12-23 2007-06-27 Bayer Schering Pharma Aktiengesellschaft Verwendung filmbildender Haarpflegepolymere und diese Polymere enthaltenden pharmazeutischen Zubereitungen und Pflaster
DK1962815T3 (da) * 2005-12-23 2010-11-15 Epinamics Gmbh Anvendelse af filmdannende hårplejepolymerer fra gruppen polyurethaner og farmaceutiske tilberedninger og plastre indeholdende nævnte polymerer
US9393218B2 (en) * 2005-12-23 2016-07-19 Epinamics Gmbh Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
CN101045041A (zh) * 2007-04-29 2007-10-03 武汉兵兵药业有限公司 含布洛芬的巴布剂及其制备方法和应用
US7883487B2 (en) * 2008-06-16 2011-02-08 Shantha Totada R Transdermal local anesthetic patch with injection port
ES2706070T3 (es) * 2012-01-17 2019-03-27 Tyme Inc Terapia de combinación para el tratamiento del cáncer
EP2914326B1 (en) * 2012-11-02 2023-08-16 Neurotronic, Inc. Chemical ablation formulations
CN105392473B (zh) * 2013-07-11 2018-06-08 宝丽制药股份有限公司 使用时产生泡沫状态的外用组合物

Also Published As

Publication number Publication date
US20190192663A1 (en) 2019-06-27
US20160193339A1 (en) 2016-07-07
US20210008214A1 (en) 2021-01-14
KR20170117390A (ko) 2017-10-23
EA035087B1 (ru) 2020-04-27
CA2968046A1 (en) 2016-06-30
JP6836991B2 (ja) 2021-03-03
JP2021020955A (ja) 2021-02-18
BR112017013329A2 (pt) 2019-09-03
ES2953955T3 (es) 2023-11-17
AU2015371253A1 (en) 2017-06-01
PH12017500836A1 (en) 2017-10-30
AU2015371253B2 (en) 2020-07-23
IL252062A0 (en) 2017-07-31
CN107405298A (zh) 2017-11-28
WO2016105530A1 (en) 2016-06-30
EP3237013B1 (en) 2023-06-07
US10786574B2 (en) 2020-09-29
JP2017538694A (ja) 2017-12-28
EP3237013C0 (en) 2023-06-07
EP3237013A1 (en) 2017-11-01
EA201791454A1 (ru) 2017-12-29

Similar Documents

Publication Publication Date Title
ZA202004557B (en) Modulatory polynucleotides
PH12017500836A1 (en) Transdermal formulations
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
MX2017008442A (es) Uso de picolinamidas como fungicidas.
TN2017000246A1 (en) Anti-c10orf54 antibodies and uses thereof
EP3145493A4 (en) Methods and compositions relating to exosomes
MX2015012334A (es) Metodos y composiciones para el control de malezas.
TW201614041A (en) Compositions for electronic devices
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
MX2020004419A (es) Polipeptidos fhbp meningococicos modificados.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
PL3102554T3 (pl) Konwersja 2,3-butanodiolu do butadienu
MX2017006019A (es) Apilimod para uso en el tratamiento de melanoma.
EP3110891A4 (en) Low-voc compositions and methods of making and using the same
PH12016502530A1 (en) Pharmaceutical compositions comprising dgla and use of same
MX379126B (es) Formulación de factor viii.
MX2016016612A (es) Formulaciones estables de undecanoato de testosterona.
PH12016501811A1 (en) Cosmetic composition for skin moisturizing containing minerals and quinoa extract
MY167350A (en) Fat-and-oil composition and chocolate
GEP20217236B (en) Composition comprising pentose and polyphenolic compound
MX2019010913A (es) Analogos de deutetrabenazina, su preparacion y uso.
PH12017500499A1 (en) Synthesis of ent-progesterone and intermediates thereof
PH12018501166B1 (en) Concentrated gibberellin solution formulations
IN2014CH00686A (es)
UA95889U (uk) Застосування екстракту солодкового кореня як противірусного засобу по відношенню до коронавірусів